TIANSHENG PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.33 CNY | -0.92% |
|
+2.36% | -15.59% |
| 2023 | Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments | CI |
| 2023 | Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test | MT |
| Sales 2020 | 1.2B 166M 13.84B | Sales 2021 | 737M 102M 8.48B | Capitalization | 1.66B 229M 19.1B |
|---|---|---|---|---|---|
| Net income 2020 | -491M -67.76M -5.65B | Net income 2021 | -67M -9.25M -771M | EV / Sales 2020 | 1.46 x |
| Net Debt 2020 | 255M 35.13M 2.93B | Net cash position 2021 | 6.89M 952K 79.34M | EV / Sales 2021 | 2.24 x |
| P/E ratio 2020 |
-3.07
x | P/E ratio 2021 |
-24.5
x | Employees | 1,307 |
| Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 53.53% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.92% | ||
| 1 week | +2.36% | ||
| Current month | -8.26% | ||
| 1 month | -6.68% | ||
| 3 months | -19.37% | ||
| 6 months | -13.05% | ||
| Current year | -15.59% |
1 week
4.03
4.38
1 month
4.035.15
Current year
4.035.97
1 year
4.035.97
3 years
4.035.99
5 years
3.619.68
10 years
3.6135.18
| Managers | Title | Age | Since |
|---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 31 | 06/18/06 |
Kai sheng Wang
DFI | Director of Finance/CFO | 50 | - |
Zonghua Tan
BRD | Director/Board Member | 52 | 11/20/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Changhong Jiang
BRD | Director/Board Member | 55 | 13/18/13 |
Hai Tian Xiong
BRD | Director/Board Member | 58 | - |
Jian Wei Yu
BRD | Director/Board Member | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 4.33 | -0.92% | 904,750 |
| 25/24/25 | 4.37 | +2.82% | 1,047,900 |
| 24/24/24 | 4.25 | +2.66% | 820,150 |
| 23/24/23 | 4.14 | +0.49% | 765,850 |
| 22/24/22 | 4.12 | -2.60% | 1,029,059 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, Shen Qi Yi lung pill, among others. The Company mainly distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
16/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -15.59% | 190M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002872 Stock
